Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase ii trial

HIGHLIGHTS

• who: Urology Clinic et al. from the Department of Oncological, Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy have published the research work: Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial, in the Journal: (JOURNAL)
• what: The authors assessed the safety and efficacy of a novel multimodal treatment paradigm for high-risk prostate cancer. Although the trial was not designed to test differences between postRP . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.